#32026R0356Commission Implementing Regulation (EU) 2026/356 of 18 February 2026 authorising endo-1,4-beta-xylanase produced with Bacillus subtilis LMG S-15136 as a feed additive for gestating sows
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This regulation authorises the use of a preparation of endo-1,4-beta-xylanase (EC 3.2.1.8) produced by Bacillus subtilis strain LMG S-15136 as a zootechnical feed additive in the functional group of digestibility enhancers. It is authorised exclusively for gestating sows at a minimum dose of 10 IU per kg of complete feed with 12% moisture. The additive is available in solid and liquid forms with a minimum activity of 400 IU/g. EFSA confirmed safety for the target animals, consumers and the environment, but classified the product as a skin and eye irritant and respiratory sensitiser, requiring protective equipment for users. The authorisation is valid until 11 March 2036.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Authorises endo-1,4-beta-xylanase (4a1606i) produced with Bacillus subtilis LMG S-15136 for gestating sows only
- Minimum content set at 10 IU/kg of complete feed (12% moisture)
- Additive must have minimum activity of 400 IU/g in solid or liquid form
+ 3 more changes with Pro
Obligations
What this law requires
Use endo-1,4-beta-xylanase preparation exclusively for gestating sows at a minimum dose of 10 IU per kg of complete feed with 12% moisture content
Ensure the additive has a minimum activity of 400 IU/g in both solid and liquid formulations
Indicate storage conditions and stability to heat treatment in the directions for use of the additive and premixtures
Establish operational procedures and organisational measures to address potential risks from the additive resulting from its classification as a skin and eye irritant and respiratory sensitiser
Provide users of the additive and premixtures with personal breathing, skin and eye protective equipment where risks cannot be eliminated by operational procedures and measures